Global Endometrial Ablation Devices Market to Grow at a Substantial CAGR of 4.95% by 2028, Estimates DelveInsight

June 6th, 2023 DelveInsight Business Research Releases

(New York, USA) The Global Endometrial Ablation Devices Market was valued at USD 3,538.60 million in 2022 and growing at a CAGR of 4.95% during the forecast period (2023 to 2028); it is expected to reach USD 4,719.50 million by 2028. The Global Endometrial Ablation Devices Market is growing owing to the increasing prevalence of abnormal vaginal bleeding, polycystic ovarian disease (PCOD), menorrhagia, and other gynecological disorders. Moreover, the innovations in product development and the growth in the surging product launches and approvals are also providing momentum to the market growth. Some of the leading players in the Endometrial Ablation Devices Market include Medtronic, Johnson & Johnson Services, Inc., Olympus, Minerva Surgical, Inc., Hologic, Inc., CooperSurgical Inc., Richard Wolf GmbH, AngioDynamics, KARL STORZ SE & Co. KG, IDOMAN-MED, Arthrex, Inc., Channel Medsystems, Inc., Gynesonics, Boston Scientific Corporation, AEGEA Medical, and others.

DelveInsight's "Endometrial Ablation Devices Market Insight, Competitive Landscape and Market Forecast 2028" research report provides the current and forecasted Endometrial Ablation Devices market size, share, and trends analysis for the next five years. Moreover, it highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.

Endometrial Ablation Devices Market: Overview

Endometrial Ablation Devices are surgical devices that are used to remove a thin layer of tissue (endometrium) that lines the uterus. The devices are used for the treatment of heavy menstrual bleeding, endometrial cancer, gynecological disorders, and others.

To provide a better understanding of the market dynamics, DelveInsight's "Endometrial Ablation Devices Market" report provides an in-depth assessment of the market by product type (cryoablation devices, hydrothermal ablators, thermal balloon ablator, radiofrequency ablators, microwave ablators, and others), end-user (hospitals & clinics, specialty clinics, and others), and geography (north america, europe, asia-pacific, and rest of the world). As per the assessment by DelveInsight, in the product type segment of the Endometrial Ablation Devices market, the radiofrequency ablators category is expected to amass a significant revenue share in the upcoming years owing to the several advantages offered by the category. The radiofrequency ablators offer speedy treatment and recovery, higher efficacy as compared to other options, more effective for the treatment of small cancers, and offer a minimally invasive approach.

Endometrial Ablation Devices Market Analysis

The demand for the Endometrial Ablation Devices is growing at an exponential rate globally. The increase in the prevalence of gynecological disorders such as menorrhagia, Polycystic Ovarian Disease (PCOD), and others, is one of the key factors for the rising demand for the Endometrial Ablation Devices. Endometrial Ablation Devices play a key role in effective treatment for menorrhagia PCOD, which is expected to stimulate the overall market growth during the forecast period.

The increasing patient preference for minimally invasive surgeries is also likely to drive the market growth. Endometrial ablation offers advantages over conventional surgeries, such as short procedure time, faster recovery, high efficiency, and lower post-treatment pain. Thus, such advantages may increase the adoption of minimally invasive treatment over the other treatment options. Furthermore, several major MedTech companies are working to develop new and innovative Endometrial Ablation Devices. The increasing developments made by the key players in the ablation segment are also contributing to the market's growth. Overall, the above-mentioned factors are contributing to the growth of the Endometrial Ablation Devices market during the forecast period from 2023-2028.

However, some of the key risk factors associated with endometrial ablation procedures such as infection, tearing of uterine wall, hemorrhage, and others are expected to hamper the Endometrial Ablation Devices market growth.

Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight @ Endometrial Ablation Devices Types and Emerging Products

Endometrial Ablation Devices – Global Market Assessment and Forecast

As per DelveInsight, among all the regions, North America is anticipated to hold the largest share of the Endometrial Ablation Devices market in the upcoming years. The growing prevalence of gynecological disorders such as PCOS, rising incidences of abnormal uterine bleeding (AUB), menorrhagia, and escalating cases of cancer such as uterine cancer among women is one of the key factors driving the North American Endometrial Ablation Devices market growth. As per the estimate, Menorrhagia affected more than 10 million American women each year, indicating one out of every five women having it. Moreover, about 66,000+ new cases of uterus cancer are expected to be diagnosed in the United States in 2023. Similarly, other countries in the region are also expected to exhibit a comparable growing trend for the new cases of uterus cancer.

Coupled with the factors mentioned above, the strong presence of MedTech companies in the region, and increasing strategic planning among the key players are also expected to drive the market of Endometrial Ablation Devices.

Interested in knowing how the market will grow by 2028? Click to get a snapshot @ Endometrial Ablation Devices Market Trends and Developments

Endometrial Ablation Devices Market – Key Developments and Breakthroughs

Over the years, the Endometrial Ablation Devices market has evolved significantly, owing to the active participation of global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered in the domain.

Some of the major advancements in the Endometrial Ablation Devices market in recent years include

Learn more about major clinical and commercial development in the market @ Endometrial Ablation Devices Market – Clinical and Commercial Development Activities

Key Companies in the Endometrial Ablation Devices Market

Globally, some of the leading MedTech giants working in the Endometrial Ablation Devices market include Medtronic, Johnson & Johnson Services, Inc., Olympus, Minerva Surgical, Inc., Hologic, Inc., CooperSurgical Inc., Richard Wolf GmbH, AngioDynamics, KARL STORZ SE & Co. KG, IDOMAN-MED, Arthrex, Inc., Channel Medsystems, Inc., Gynesonics, Boston Scientific Corporation, AEGEA Medical, and others. Owing to the rising demand and favorable growth opportunities for revenue generation, several new players are anticipated to enter the market, thereby leading to high competitiveness in the domain.

Learn how new players’ entries will transform the market dynamics in the coming years @ Endometrial Ablation Devices Competitive Landscape

Scope of the Endometrial Ablation Devices Market Report:

Table of Content

Reach out to us to get a more detailed overview of the market @ Endometrial Ablation Devices Market Insights and Competitive Landscape

Other Trending Healthcare Reports by DelveInsight:

Bronchial Spasm Market | Meningioma Market | Necrotizing Enterocolitis Market Hyperhidrosis Market |Bacterial Meningitis Market | Anaphylaxis Market | Neurostimulation Devices Market | Intracranial Pressure Monitoring Devices Market | Acute Pharyngitis Market | Hepatitis B Virus Market | Thymic Carcinoma Market | Bladder Cancer Market | Spasticity Market | Interbody Cages Market | Helicobacter Pylori Infection Market | Intravenous Immunoglobulin Market | Opioid Induced Constipation Market | Ophthalmic Imaging Equipment Market | Epilepsy Market | Pharmaceutical Consulting Companies | Acquired Immunodeficiency Syndrome Market | Image Guided Surgery Devices Market | Androgenetic Alopecia Market | Acute Lung Injury Market | Astigmatism Market | Familial Primary Pulmonary Hypertension Market | Progressive Multifocal Leukoencephalopathy Market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Leverage the potential of consulting services to overcome the competition in the highly evolving and dynamic healthcare market with Healthcare Portfolio Management Solutions and Healthcare Partner Identification Solutions

Contact Us

Shruti Thakur

Manager (Marketing & Branding)

[email protected]

+1(919)321-6187.

Healthcare Consulting

Sign up and submit a press release